𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinic

✍ Scribed by Gregg J. Silverman

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
68 KB
Volume
52
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Absent factor II in systemic lupus eryth
Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy
✍ Ethan A. Natelson; Gerald S. Cyprus; Robert A. Hettig πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 329 KB πŸ‘ 2 views

## Abstract This report describes a patient with active systemic lupus erythematosus (SLE) who evidenced severe bleeding consequent to a profound and isolated reduction in plasma factor II (prothrombin) activity. Absence of the factor is documented by immunologic means and its return after corticos

Development of the anti-Ro autoantibody
Development of the anti-Ro autoantibody response in a patient with systemic lupus erythematosus
✍ R. Hal Scofield; Fenchung Zhang; Biji T. Kurien; Camille J. Anderson; Morris Rei πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

To characterize the initial events in anti-Ro production by a patient with systemic lupus erythematosus, in whom this autoantibody is developing. Methods. The immune response to the Ro ribonucleoprotein and other autoantigens were studied by enzyme-linked immunosorbent assay for IgG and IgM, by iso

Anti–lipoprotein lipase antibodies: A ne
Anti–lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus?
✍ JozΓ©lio Freire de Carvalho; Eduardo Ferreira Borba; Vilma Santos Trindade Viana; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

## Abstract ## Objective The novel description of antibodies to lipoprotein lipase (anti‐LPL) associated with dyslipoproteinemia prompted us to analyze the association of anti‐LPL with clinical and serologic features in patients with systemic lupus erythematosus (SLE) and its link to markers of in